{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T12:06:43Z","timestamp":1793016403353,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T00:00:00Z","timestamp":1540425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s12253-018-0488-3","type":"journal-article","created":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T02:25:43Z","timestamp":1540434343000},"page":"1279-1284","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The Role of Testin in Human Cancers"],"prefix":"10.1007","volume":"25","author":[{"given":"Aneta","family":"Popiel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Kobierzycki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Dzi\u0119giel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,25]]},"reference":[{"key":"488_CR1","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1111\/j.1349-7006.2010.01497.x","volume":"101","author":"H Qiu","year":"2010","unstructured":"Qiu H, Zhu J, Yuan C, Yan S, Yang Q, Kong B (2010) Frequent hypermethylation and loss of heterozygosity of the testis derived transcript gene in ovarian cancer. Cancer Sci 101:1255\u20131260. https:\/\/doi.org\/10.1111\/j.1349-7006.2010.01497.x","journal-title":"Cancer Sci"},{"key":"488_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/apm.12361","volume":"123","author":"R Dong","year":"2015","unstructured":"Dong R, Pu H, Wang Y, Yu J, Lian K, Mao C (2015) TESTIN was commonly hypermethylated and involved in the epithelial-mesenchymal transition of endometrial cancer. APMIS 123:394\u2013400. https:\/\/doi.org\/10.1111\/apm.12361","journal-title":"APMIS"},{"key":"488_CR3","first-page":"1","volume":"9","author":"H Ma","year":"2010","unstructured":"Ma H, Weng D, Chen Y, Huang W, Pan K, Wang H, Sun J, Wang Q, Zhou Z, Wang H, Xia J (2010) Extensive analysis of D7S486 in primary gastric cancer supports TESTIN as a candidate tumor suppressor gene. Mol Cancer 9:1\u201310","journal-title":"Mol Cancer"},{"key":"488_CR4","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1002\/ijc.20337","volume":"111","author":"L Ch\u00eane","year":"2004","unstructured":"Ch\u00eane L, Giroud C, Desgrandchamps F, Boccon-Gibod L, Cussenot O, Berthon P, Latil A (2004) Extensive analysis of the 7q31 region in human prostate tumors supports TES as the best candidate tumor suppressor gene. Int J Cancer 111:798\u2013804. https:\/\/doi.org\/10.1002\/ijc.20337","journal-title":"Int J Cancer"},{"key":"488_CR5","doi-asserted-by":"crossref","unstructured":"Li H, Huang K, Gao L, Wang L, Niu Y, Liu H (2016) TES inhibits colorectal cancer progression through activation of p38. Oncotagret 7","DOI":"10.18632\/oncotarget.9961"},{"key":"488_CR6","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1158\/1078-0432.806.11.2","volume":"11","author":"M Sarti","year":"2005","unstructured":"Sarti M, Sevignani C, Calin GA, Aqeilan R, Shimizu M, Pentimalli F, Picchio MC, Godwin A, Rosenberg A, Drusco A, Negrini M, Croce CM (2005) Adenoviral transduction of TESTIN gene into breast and uterine Cancer cell lines promotes apoptosis and tumor reduction in vivo. Clin Cancer Res 11:806\u2013813","journal-title":"Clin Cancer Res"},{"key":"488_CR7","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.3892\/or.2016.5316","volume":"37","author":"W Ming","year":"2017","unstructured":"Ming W, Qian W, Peng W-J, Hu J-F, Wang Z-Y, Liu H, Huang L-N (2017) Testin is a tumor suppressor in non-small cell lung cancer. Oncol Rep 37:1027\u20131035. https:\/\/doi.org\/10.3892\/or.2016.5316","journal-title":"Oncol Rep"},{"issue":"3","key":"488_CR8","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1001\/archoto.2008.560","volume":"135","author":"Esra Gunduz","year":"2009","unstructured":"Gunduz E, Gunduz M, Beder L, Nagatsuka H, Fukushima K, Sutcu R, Delibas N, Yamanaka N, Shimizu K, Nagai N, CM C, AG K, M E, DM P, JM C, MI E, JC L, V S, S T, XL W, JC Z, JS Z, JC Z, JC Z, T O, M G, C T, M S, A D, L C, W M, F B, B T (2009) Downregulation of TESTIN and its association with Cancer history and a tendency toward poor survival in head and neck squamous cell carcinoma. Arch Otolaryngol Neck Surg 135:254. https:\/\/doi.org\/10.1001\/archoto.2008.560 , 260","journal-title":"Archives of Otolaryngology\u2013Head & Neck Surgery"},{"key":"488_CR9","unstructured":"Li S, Xue M HL (2016) Relationship between Testin expression and clinicopathological characteristics in nasopharyngeal carcinoma patients. 310\u20133"},{"key":"488_CR10","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.3892\/ol.2016.5077","volume":"12","author":"G Steponaitis","year":"2016","unstructured":"Steponaitis G, Kazlauskas A, Skiriute D, Valiulyte I, Skauminas K, Tamasauskas A, Vaitkiene P (2016) Testin (TES) as a candidate tumour suppressor and prognostic marker in human astrocytoma. Oncol Lett 12:3305\u20133311. https:\/\/doi.org\/10.3892\/ol.2016.5077","journal-title":"Oncol Lett"},{"key":"488_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-017-0980-8","volume":"34","author":"E Prieto-Garc\u00eda","year":"2017","unstructured":"Prieto-Garc\u00eda E, D\u00edaz-Garc\u00eda CV, Garc\u00eda-Ruiz I, Agull\u00f3-Ortu\u00f1o MT (2017) Epithelial-to-mesenchymal transition in tumor progression. Med Oncol 34:122. https:\/\/doi.org\/10.1007\/s12032-017-0980-8","journal-title":"Med Oncol"},{"issue":"5","key":"488_CR12","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1021\/acs.jproteome.7b00034","volume":"16","author":"Stefano Sala","year":"2017","unstructured":"Sala S, Van Troys M, Medves S, Catillon M, Timmerman E, Staes A, Schaffner-Reckinger E, Gevaert K, Ampe C (2017) Expanding the interactome of TES by exploiting TES modules with different subcellular localizations. J Proteome Res acs.jproteome.7b00034. https:\/\/doi.org\/10.1021\/acs.jproteome.7b00034","journal-title":"Journal of Proteome Research"},{"key":"488_CR13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s11010-008-9901-7","volume":"320","author":"Y Zhong","year":"2009","unstructured":"Zhong Y, Zhu J, Wang Y, Zhou J, Ren K, Ding X, Zhang J (2009) LIM domain protein TES changes its conformational states in different cellular compartments. Mol Cell Biochem 320:85\u201392. https:\/\/doi.org\/10.1007\/s11010-008-9901-7","journal-title":"Mol Cell Biochem"},{"key":"488_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s007090200000","volume":"219","author":"T Khurana","year":"2002","unstructured":"Khurana T, Khurana B, Noegel a a (2002) LIM proteins: association with the actin cytoskeleton. Protoplasma 219:1\u201312. https:\/\/doi.org\/10.1007\/s007090200000","journal-title":"Protoplasma"},{"key":"488_CR15","doi-asserted-by":"crossref","unstructured":"Sala S, Catillon M, Hadzic E, Schaffner-reckinger E, Troys M Van, Ampe C (2017) The PET and LIM1\u20132 domains of testin contribute to intramolecular and homodimeric interactions. 1:1\u201321","DOI":"10.1371\/journal.pone.0177879"},{"key":"488_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151341","volume":"11","author":"RJ Weeks","year":"2016","unstructured":"Weeks RJ, Ludgate JL, LeM\u00e9e G, Morison IM (2016) TESTIN induces rapid death and suppresses proliferation in childhood B acute lymphoblastic Leukaemia cells. PLoS One 11:e0151341. https:\/\/doi.org\/10.1371\/journal.pone.0151341","journal-title":"PLoS One"},{"key":"488_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/srep17225","volume":"5","author":"J Oldenburg","year":"2015","unstructured":"Oldenburg J, van der Krogt G, Twiss F, Bongaarts A, Habani Y, Slotman JA, Houtsmuller A, Huveneers S, de Rooij J (2015) VASP, zyxin and TES are tension-dependent members of focal Adherens junctions independent of the \u03b1-catenin-vinculin module. Sci Rep 5:17225. https:\/\/doi.org\/10.1038\/srep17225","journal-title":"Sci Rep"},{"key":"488_CR18","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1242\/jcs.00278","volume":"116","author":"AS Coutts","year":"2003","unstructured":"Coutts AS (2003) TES is a novel focal adhesion protein with a role in cell spreading. J Cell Sci 116:897\u2013906. https:\/\/doi.org\/10.1242\/jcs.00278","journal-title":"J Cell Sci"},{"key":"488_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/geno.2000.6272","volume":"12","author":"C Tatarelli","year":"2000","unstructured":"Tatarelli C, Linnenbach A, Mimori K, Croce CM (2000) Characterization of the human TESTIN gene localized in the FRA7G region at 7q31. 2 Genomics 12:1\u201312. https:\/\/doi.org\/10.1006\/geno.2000.6272","journal-title":"2 Genomics"},{"key":"488_CR20","doi-asserted-by":"publisher","first-page":"980","DOI":"10.12659\/MSM.890544","volume":"20","author":"Z Gu","year":"2014","unstructured":"Gu Z, Ding G, Liang K, Zhang H, Guo G, Zhang L, Cui J (2014) TESTIN suppresses tumor growth and invasion via manipulating cell cycle progression in endometrial carcinoma. Med Sci Monit 20:980\u2013987. https:\/\/doi.org\/10.12659\/MSM.890544","journal-title":"Med Sci Monit"},{"key":"488_CR21","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.molcel.2007.10.033","volume":"28","author":"B Bo\u00ebda","year":"2007","unstructured":"Bo\u00ebda B, Briggs DC, Higgins T, Garvalov BK, Fadden AJ, McDonald NQ, Way M (2007) Tes, a specific Mena interacting partner, breaks the rules for EVH1 binding. Mol Cell 28:1071\u20131082. https:\/\/doi.org\/10.1016\/j.molcel.2007.10.033","journal-title":"Mol Cell"},{"key":"488_CR22","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/cm.10162","volume":"57","author":"E Griffith","year":"2004","unstructured":"Griffith E, Coutts AS, Black DM (2004) Characterisation of chicken TES and its role in cell spreading and motility. Cell Motil Cytoskeleton 57:133\u2013142. https:\/\/doi.org\/10.1002\/cm.10162","journal-title":"Cell Motil Cytoskeleton"},{"key":"488_CR23","doi-asserted-by":"publisher","first-page":"10947","DOI":"10.1073\/pnas.0504934102","volume":"102","author":"A Drusco","year":"2005","unstructured":"Drusco A, Zanesi N, Roldo C, Trapasso F, Farber JL, Fong LY, Croce CM (2005) Knockout mice reveal a tumor suppressor function for Testin. PNAS 102:10947\u201310951","journal-title":"PNAS"},{"key":"488_CR24","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1111\/cas.12020","volume":"103","author":"J Zhu","year":"2012","unstructured":"Zhu J, Li X, Kong X, Moran MS, Su P, Haffty BG, Yang Q (2012) Testin is a tumor suppressor and prognostic marker in breast cancer. Cancer Sci 103:2092\u20132101. https:\/\/doi.org\/10.1111\/cas.12020","journal-title":"Cancer Sci"},{"key":"488_CR25","doi-asserted-by":"publisher","first-page":"824","DOI":"10.3892\/or.2013.2502","volume":"30","author":"M Sarti","year":"2013","unstructured":"Sarti M, Pinton S, Limoni C, Carbone GM, Pagani O, Cavalli F, Catapano CV (2013) Differential expression of testin and survivin in breast cancer subtypes. Oncol Rep 30:824\u2013832. https:\/\/doi.org\/10.3892\/or.2013.2502","journal-title":"Oncol Rep"},{"key":"488_CR26","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1038\/sj.onc.1204433","volume":"20","author":"ES Tobias","year":"2001","unstructured":"Tobias ES, Hurlstone AFL, Mackenzie E, Mcfarlane R, Black DM (2001) The TES gene at 7q31 . 1 is methylated in tumours and encodes a novel growth-suppressing LIM domain protein. Oncogene 20:2844\u20132853","journal-title":"Oncogene"},{"key":"488_CR27","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/sj.onc.1209805","volume":"26","author":"W Mueller","year":"2007","unstructured":"Mueller W, Nutt CL, Ehrich M, Riemenschneider MJ, von Deimling A, van den Boom D, Louis DN (2007) Downregulation of RUNX3 and TES by hypermethylation in glioblastoma. Oncogene 26:583\u2013593. https:\/\/doi.org\/10.1038\/sj.onc.1209805","journal-title":"Oncogene"},{"key":"488_CR28","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0888-7543(02)00029-0","volume":"81","author":"SY Han","year":"2003","unstructured":"Han SY, Druck T, Huebner K (2003) Candidate tumor suppressor genes at FRA7G are coamplified with MET and do not suppress malignancy in a gastric cancer. Genomics 81:105\u2013107. https:\/\/doi.org\/10.1016\/S0888-7543(02)00029-0","journal-title":"Genomics"},{"key":"488_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s40661-017-0039-8","volume":"4","author":"MK Frey","year":"2017","unstructured":"Frey MK, Pothuri B (2017) Homologous recombination deficiency (HRD) testing in ovarian cancer clinical practice: a review of the literature. Gynecol Oncol Res Pract 4:4. https:\/\/doi.org\/10.1186\/s40661-017-0039-8","journal-title":"Gynecol Oncol Res Pract"},{"key":"488_CR30","first-page":"1009","volume":"3","author":"I Bi\u00e8che","year":"1997","unstructured":"Bi\u00e8che I, Khodja a DK, Lidereau R (1997) Genetic alteration mapping on chromosome 7 in primary breast cancer. Clin Cancer Res 3:1009\u20131016","journal-title":"Clin Cancer Res"},{"key":"488_CR31","first-page":"1347","volume":"55","author":"JC Zenklusen","year":"1995","unstructured":"Zenklusen JC, Thompson JC, Conti CJ, Klein-Szanto AJP (1995) Frequent loss of heterozygosity in human primary squamous cell and Colon carcinomas at 7q31.1: evidence for a broad range tumor suppressor gene. Cancer Res 55:1347\u20131350","journal-title":"Cancer Res"},{"key":"488_CR32","doi-asserted-by":"publisher","unstructured":"Jia X, Shanmugam C, Paluri RK, Jhala NC, Behring P, Katkoori VR, Sugandha SP, Bae S (2017) Prognostic value of loss of heterozygosity and sub-cellular localization of SMAD4 varies with tumor stage in colorectal cancer. 8:20198\u201320212. https:\/\/doi.org\/10.18632\/oncotarget.15560","DOI":"10.18632\/oncotarget.15560"},{"key":"488_CR33","first-page":"453","volume":"18","author":"K Matsuura","year":"1998","unstructured":"Matsuura K, Shiga K, Yokoyama J, Saijo S, Miyagi T, Takasaka T (1998) Loss of heterozygosity of chromosome 9p21 and 7q31 is correlated with high incidence of recurrent tumor in head and neck squamous cell carcinoma. Anticancer Res 18:453\u2013458","journal-title":"Anticancer Res"},{"key":"488_CR34","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0145-2126(98)00159-3","volume":"23","author":"M Koike","year":"1999","unstructured":"Koike M, Tasaka T, Spira S, Tsuruoka N, Phillip Koeffler H (1999) Allelotyping of acute myelogenous leukemia: loss of heterozygosity at 7q31.1 (D7S486) and q33-34 (D7S498, D7S505). Leuk Res 23:307\u2013310. https:\/\/doi.org\/10.1016\/S0145-2126(98)00159-3","journal-title":"Leuk Res"},{"key":"488_CR35","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/1476-4598-9-163","volume":"9","author":"RJ Weeks","year":"2010","unstructured":"Weeks RJ, Kees UR, Song S, Morison IM (2010) Silencing of TESTIN by dense biallelic promoter methylation is the most common molecular event in childhood acute lymphoblastic leukaemia. Mol Cancer 9:163. https:\/\/doi.org\/10.1186\/1476-4598-9-163","journal-title":"Mol Cancer"},{"key":"488_CR36","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1038\/sj.onc.1201448","volume":"15","author":"V Shridhar","year":"1997","unstructured":"Shridhar V, Sun QC, Miller OJ, Kalemkerian GP, Petros J, Smith DI (1997) Loss of heterozygosity on the long arm of human chromosome 7 in sporadic renal cell carcinomas. Oncogene 15:2727\u20132733. https:\/\/doi.org\/10.1038\/sj.onc.1201448","journal-title":"Oncogene"},{"key":"488_CR37","first-page":"3808","volume":"56","author":"A Achille","year":"1996","unstructured":"Achille A, Biasi MO, Zamboni G, Bogina G, Magalini AR, Pederzoli P, Perucho M, Scarpa A (1996) Chromosome 7q allelic losses in pancreatic carcinoma. Cancer Res 56:3808\u20133813","journal-title":"Cancer Res"},{"key":"488_CR38","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/cas.13116","volume":"108","author":"O Hino","year":"2017","unstructured":"Hino O, Kobayashi T (2017) Mourning Dr. Alfred G. Knudson: the two-hit hypothesis, tumor suppressor genes, and the tuberous sclerosis complex. Cancer Sci 108:5\u201311. https:\/\/doi.org\/10.1111\/cas.13116","journal-title":"Cancer Sci"},{"key":"488_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-017-0427-5","volume":"75","author":"A Nasir","year":"2015","unstructured":"Nasir A, Holzer TR, Man M, Benjamin LE, Melemed AS, Schade AE (2015) Differential expression of VEGFR2 protein in HER2 positive primary human breast cancer: potential relevance to newer anti-angiogenic therapies. Cancer Res 75:1\u201312. https:\/\/doi.org\/10.1186\/s12935-017-0427-5","journal-title":"Cancer Res"},{"key":"488_CR40","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00577.2012","volume-title":"The history of matrix metalloproteinases\u00a0: milestones , myths , and misperceptions. Trabslational Physiol","author":"RP Iyer","year":"2012","unstructured":"Iyer RP, Patterson NL, Fields GB, Lindsey ML (2012) The history of matrix metalloproteinases\u00a0: milestones , myths , and misperceptions. Trabslational Physiol. https:\/\/doi.org\/10.1152\/ajpheart.00577.2012"},{"key":"488_CR41","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1002\/hep.24577","volume":"54","author":"J Fang","year":"2011","unstructured":"Fang J, Zhou H, Zeng C, Yang J, Liu Y, Huang X, Zhang J, Guan X, Zhuang S (2011) MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression. Hepatology 54:1729\u20131740. https:\/\/doi.org\/10.1002\/hep.24577","journal-title":"Hepatology"},{"key":"488_CR42","doi-asserted-by":"publisher","first-page":"R36","DOI":"10.1186\/bcr2590","volume":"12","author":"K Holm","year":"2010","unstructured":"Holm K, Hegardt C, Staaf J, Vallon-Christersson J, J\u00f6nsson G, Olsson H, Borg A, Ringn\u00e9r M (2010) Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns. Breast Cancer Res 12:R36. https:\/\/doi.org\/10.1186\/bcr2590","journal-title":"Breast Cancer Res"},{"key":"488_CR43","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/JCI39104.1420","volume":"119","author":"R Kalluri","year":"2009","unstructured":"Kalluri R, R a W (2009) Review series the basics of epithelial-mesenchymal transition. J Clin Invest 119:1420\u20131428. https:\/\/doi.org\/10.1172\/JCI39104.1420","journal-title":"J Clin Invest"},{"key":"488_CR44","doi-asserted-by":"publisher","first-page":"9744","DOI":"10.3748\/wjg.v20.i29.9744","volume":"20","author":"V Grossi","year":"2014","unstructured":"Grossi V, Peserico A, Tezil T, Simone C (2014) p38\u03b1 MAPK pathway: a key factor in colorectal cancer therapy and chemoresistance. World J Gastroenterol 20:9744\u20139758. https:\/\/doi.org\/10.3748\/wjg.v20.i29.9744","journal-title":"World J Gastroenterol"},{"key":"488_CR45","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1002\/pros.22627","volume":"73","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Guo Z, Du T, Chen J, Wang W, Xu K, Lin T, Huang H (2013) Prostate specific membrane antigen (PSMA): a novel modulator of p38 for proliferation, migration, and survival in prostate cancer cells. Prostate 73:835\u2013841. https:\/\/doi.org\/10.1002\/pros.22627","journal-title":"Prostate"},{"key":"488_CR46","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.4161\/cc.6.20.4774","volume":"6","author":"L Hui","year":"2007","unstructured":"Hui L, Bakiri L, Stepniak E, Wagner EF (2007) p38alpha: a suppressor of cell proliferation and tumorigenesis. Cell Cycle 6:2429\u20132433. https:\/\/doi.org\/10.4161\/cc.6.20.4774","journal-title":"Cell Cycle"},{"key":"488_CR47","first-page":"267","volume":"27","author":"W Huang","year":"2008","unstructured":"Huang W, Weng DS, Pan ZZ, Pan K, Ding PR, Zhou JW, Wang H, Zhang HK, Li JJ, Xia JC (2008) Expression and clinical significance of TESTIN in primary gastric cancer. Chinese J Cancer 27:267\u2013270","journal-title":"Chinese J Cancer"},{"issue":"2","key":"488_CR48","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.3892\/or.2016.5316","volume":"37","author":"Ming Wang","year":"2016","unstructured":"Wang M, Wang Q, Peng W, Hu J (2017) Testin is a tumor suppressor in non-small cell lung cancer. 1027\u20131035. https:\/\/doi.org\/10.3892\/or.2016.5316","journal-title":"Oncology Reports"}],"container-title":["Pathology & Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-018-0488-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12253-018-0488-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-018-0488-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,4]],"date-time":"2022-09-04T16:23:21Z","timestamp":1662308601000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12253-018-0488-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,25]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["488"],"URL":"https:\/\/doi.org\/10.1007\/s12253-018-0488-3","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"value":"1219-4956","type":"print"},{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,25]]},"assertion":[{"value":"29 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}